Reducing the Harm of Prostate Cancer Screening: Repeated Prostate-Specific Antigen Testing-Reference-Cited by-同舟云学术

Reducing the Harm of Prostate Cancer Screening: Repeated Prostate-Specific Antigen Testing

Published:2016-01 Issue:1 Volume:91 Page:17-22
ISSN:0025-6196
Container-title:Mayo Clinic Proceedings
language:en
Short-container-title:Mayo Clinic Proceedings

Author:

Lavallée Luke T.,Binette Andrew,Witiuk Kelsey,Cnossen Sonya,Mallick Ranjeeta,Fergusson Dean A.,Momoli Franco,Morash Chris,Cagiannos Ilias,Breau Rodney H.

Publisher

Elsevier BV

Subject

General Medicine

Reference29 articles.

1. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer;Catalona;N Engl J Med,1991

2. Howlader N, Noone AM, Krapcho M, et al, eds. SEER Cancer Statistics Review, 1975-2011 [based on November 2013 SEER data submission]. National Cancer Institute website. http://seer.cancer.gov/csr/1975_2011/. Published April 2014. Updated December 17, 2014. Accessed February 1, 2015.

3. Canadian Cancer Statistics 2014,2014

4. Contemporary trends in low risk prostate cancer: risk assessment and treatment;Cooperberg;J Urol,2007

5. Overdiagnosis due to prostate-specific antigen screening: lessons from U. S. prostate cancer incidence trends;Etzioni;J Natl Cancer Inst,2002

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Normalised repeat serum prostate-specific antigen: associations with age and magnetic resonance imaging results;Scandinavian Journal of Urology;2024-03-06

2. LANDMARKS AND MODERN APPROACHES IN PROSTATE CANCER DIAGNOSIS;Themed collection of papers from Foreign international scientific conference «Joint innovation - joint development». Part 2. by HNRI «National development» in cooperation with PS of UA. October 2023. - Harbin (China);2024-01-18

3. Lipid metabolism-related miRNAs with potential diagnostic roles in prostate cancer;Lipids in Health and Disease;2023-03-14

4. Prostate-specific antigen kinetics contributes to decision making for biopsy referral: the predictive implication for PSA retest in patients with elevated PSA levels;Prostate International;2023-03

5. High expression of KNL1 in prostate adenocarcinoma is associated with poor prognosis and immune infiltration;Frontiers in Genetics;2023-01-06